4/A//SEC Filing
SCICLONE PHARMACEUTICALS INC 4/A
Accession 0001140361-08-001861
CIK 0000880771operating
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 2:14 PM ET
Size
18.4 KB
Accession
0001140361-08-001861
Insider Transaction Report
Form 4/AAmended
SIGMA TAU FINANZIARIA SPA
10% Owner
Transactions
- Purchase
Common Stock
2008-01-14$2.00/sh+200$400→ 6,423,189 total(indirect: I)
DEFIANTE FARMACEUTICA LDA
10% Owner
Transactions
- Purchase
Common Stock
2008-01-14$2.00/sh+200$400→ 6,423,189 total(indirect: I)
Footnotes (2)
- [F1]The original report on Form 4 that was filed on January 15, 2008 mistakenly stated that Defiante Farmaceutica, L.D.A. (?Defiante?) acquired 400 shares of SciClone Pharmaceuticals, Inc (?SciClone?) when in fact it had acquired only 200 shares. This Form 4 is filed to amend the Form 4 originally filed on January 15, 2008 to reflect the acquisition of only 200 shares of SciClone. The 200 extra shares were also inadvertently included in the Form 4 filed by the reporting persons on January 17, 2008.
- [F2]Shares directly owned by Defiante Farmaceutica, L.D.A. (?Defiante?). Defiante is 58% directly owned by Sigma Tau Finanzaria S.p.A. ("Sigma Tau") and 42% directly owned by Sigma Tau's wholly-owned subsidiary, Sigma Tau International S.A.
Documents
Issuer
SCICLONE PHARMACEUTICALS INC
CIK 0000880771
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000880771
Filing Metadata
- Form type
- 4/A
- Filed
- Jan 23, 7:00 PM ET
- Accepted
- Jan 24, 2:14 PM ET
- Size
- 18.4 KB